Syringes Companies

The Syringes Market is witnessing significant growth driven by the rising prevalence of chronic diseases and the increasing demand for vaccinations worldwide. With advancements in healthcare infrastructure, there's a surge in the adoption of syringes for administering medications, vaccines, and diagnostic purposes.

Strategies for Market Share Growth:

In this competitive environment, players adopt various strategies to gain and maintain market share. These include:

• 
  Product innovation: Developing new and improved syringe designs with features like improved safety mechanisms, better needle quality, and automation capabilities.


• 
  Geographic expansion: Entering new markets, particularly in emerging economies with growing healthcare needs.


• 
  Mergers and acquisitions: Expanding product portfolios and geographic reach through strategic acquisitions and partnerships.


• 
  Cost leadership: Optimizing manufacturing processes and supply chains to offer competitive pricing.


• 
  Focus on emerging segments: Targeting specific segments with high growth potential, such as prefilled syringes for biologics and safety syringes for improved healthcare worker safety.

Factors Affecting Market Share:

Several factors influence a company's market share in the syringes market:

• 
  Product portfolio: Offering a diverse and technologically advanced product portfolio catering to various needs.


• 
  Manufacturing capacity and cost efficiency: Ability to produce high-quality syringes at competitive costs.


• 
  Distribution network and sales channels: Strong distribution network and effective sales channels to reach healthcare providers and patients.


• 
  Brand reputation and quality: Established brand reputation and commitment to quality control.


• 
  Regulatory compliance: Adherence to stringent regulatory requirements for medical devices.

Key companies in the Syringes Market include

• 
  

  Becton, Dickinson, and Company (U.S.)

  
  


• 
  

  Terumo Corporation (Japan)

  
  


• 
  

  Medtronic plc (Ireland)

  
  


• 
  

  Smiths Medical (U.S.)

  
  


• 
  

  B. Braun Medical Inc. (U.S.)

  
  


• 
  

  NIPRO Corporation (Japan)

  
  


• 
  

  Hindustan Syringes & Medical Devices Limited (India)

  
  


• 
  

  Gerresheimer AG (Germany)

  
  


• 
  

  SCHOTT AG (Germany)

  
  


• 
  

  CODAN Medizinische Geräte GmbH & Co KG (Germany)

  
  

Recent Developments

October 2023: The World Health Organization (WHO) prequalified a new low-cost, auto-disable safety syringe developed by HMD, aiming to improve immunization safety and waste management in low- and middle-income countries.

November 2023: B. Braun Melsungen AG announced its partnership with a leading pharmaceutical company to develop and manufacture prefilled syringes for a new biologic drug.

December 2023: The US Food and Drug Administration (FDA) approved a new connected syringe from BD, which allows for remote monitoring of medication adherence and injection data.

September 2019: In September 2019, Braun Melsungen, in partnership with Royal Philips, introduced the Vision Needle Tip Tracking, a technology designed to ensure precise needle positioning within the body. This innovation assists anesthesiologists in safely and effectively conducting anesthesia procedures, particularly in avoiding complications related to peripheral nerve blocks

December 2020: In December 2020, Smiths Medical introduced the Echoglo needle for peripheral nerve block procedures. This needle features a combination of clockwise and counter-clockwise grooves, strategically designed to reflect acoustic energy to the transducer, thereby enhancing echogenic visibility during medical procedures